This is the authors' abstract. We don't add key points for this paper.
A new glucoee polymer, icodextrin, related to maltose, is in increasing use as a peritoneal dialysis fluid. We report on adverse events seen in our unit during a 12-month period after the introduction of this reagent.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Goldsmith et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: